Search results
FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD
AOL· 12 hours agoFood and Drug Administration has voted against the use of MDMA — commonly referred to as ecstasy or...
MDMA drug for PTSD panned by FDA advisers citing trial flaws - The Boston Globe
The Boston Globe· 3 hours agoAdvisers to the Food and Drug Administration voted 9 to 2 that developer Lykos Therapeutics Inc.’s...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 1 day agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
US FDA warns on risks linked to sulfite-containing compounded drugs
Reuters· 1 hour agoThe U.S. Food and Drug Administration said on Wednesday it had alerted healthcare professionals,...
JD Supra: FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and...
JD Supra· 5 hours agoOn April 25, 2024, the FDA published a notice of availability in the Federal Register for its revised draft guidance, entitled “Promotional Labeling and Advertising Considerations ...
FDA Panel Rejects MDMA-Assisted Therapy For PTSD
Forbes· 18 hours agoTherapeutics, a company formed by the Multidisciplinary Association for Psychedelic Studies (MAPS) to develop the treatment. After listening to public...
FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD
Scripps News via AOL· 9 hours agoA panel of advisers to the U.S. Food and Drug Administration has voted against the use of MDMA —...
FDA objects to ecstasy for treating PTSD patients
The Washington Times· 8 hours agoLykos Therapeutics and the Multidisciplinary Association for Psychedelic Studies tested the psychedelic drug, which can heighten feelings of intimacy and...
New Draft FDA Guidance for Dietary Supplement Master Files | JD Supra
JD Supra· 16 hours agoFDA has developed a new set of requirements for documenting the safety of dietary supplement ingredients. To that end FDA is creating new guidance related ...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
MPR News· 12 hours agoIt represents a major setback for proponents of the drug and its sponsor Lykos Therapeutics, potentially jeopardizing FDA approval of the treatment. Following public comment ...